As VP of Technical Sales & Partners at Aizon, Cristian Marfà brings over 25 years of experience in industrial software, automation, and digital transformation, with a laser focus on the pharmaceutical and biotech sectors. Cristian’s expertise lies in helping organizations leverage AI to transform their manufacturing processes, improving efficiency and ensuring compliance while driving significant business value.
Before Aizon, Cristian played pivotal roles at AVEVA-Wonderware and Siemens, leading the deployment of advanced manufacturing systems across multiple industries. Today, at Aizon, he is on the cutting edge of AI-driven solutions, helping pharma companies navigate the complexities of modern manufacturing. At the Pharma MES speaking slot, Cristian will share how AI can unlock new levels of operational efficiency and quality, turning traditional manufacturing approaches on their head.
The Pop in Your Job: Cristian’s passion lies in harnessing the power of AI and digital solutions to solve real-world challenges in manufacturing. What drives him is knowing that the technologies Aizon deploys are making a tangible difference—helping pharma manufacturers achieve operational excellence and improve patient outcomes. At Aizon, Cristian’s mission is clear: to drive the industry forward through innovation and help clients reach their highest potential.
Solution Study
Tuesday, September 23
10:00 am - 10:30 am
Live in Berlin
Less Details
In pharma manufacturing, MES and eBR projects have been crucial in moving away from paper and strengthening compliance. But they are also significant undertakings, with large programs, long timelines, and outcomes that can take years to fully materialize, if ever. Not all sites are ready to invest at that scale, and in practice many business cases are never fully met. The result is an industry still running at two speeds: while some plants have achieved high levels of digitization, nearly half of manufacturing sites continue to rely on paper batch records. At the same time, AI has emerged as a powerful tool. While much of the current noise highlights personal productivity, the real and lasting impact will come from applying intelligence directly to manufacturing operations. Gains in yield, reduced COGS, and expanded capacity translate into measurable outcomes for both the P&L and patients. Aizon’s Intelligent Batch Record (iBR) builds on good data to provide digital guardrails that guarantee quality, while using industrialized GMP AI to optimize processes and accelerate decision making. Moving from paper to AI is possible in just 100 days. In this session, you will learn more about:
Tech Take
Tuesday, September 23
10:40 am - 11:00 am
Live in Berlin
Less Details
Ready to leave paper-based complexity behind? Join our tech talk to witness how Aizon can transform your operations from manual batch records to fully digital and GxP AI-driven processes—fast. We’ll demonstrate:
Attend this session to see firsthand how pragmatic digitization and intelligent automation can become your new standard in just 100 days.